REVIEW Tiquizium bromide is a quaternary ammonium salt, an antimuscarinic agent used as a antispasdomdic pain mediating drug. The compound also demonstrates bronchodilatory effect on airway smooth muscle in vitro, and also in patients with chronic obstructive pulmonary disease (COPD).
Koshinaka, Eiichi; Ogawa, Nobuo; Kurata, Sakae; Yamagishi, Kagari; Kubo, Shinji; Matsubara, Issei; Kato, Hideo Studies on antispasmodics. I. Synthesis and anticholinergic activity of 1-, 2-, and 3-diarylmethylenequinolizidine quaternary ammonium salts. Chemical & Pharmaceutical Bulletin (1979), 27(6), 1454-63.
Oshita, Masafumi; Ohashi, Tetsuo; Morikawa, Kouji; Kato, Hideo; Ito, Yasuo; Muramatsu, Ikunobu; Studies on the affinity and selectivity of tiquizium bromide (HSR-902), a novel spasmolytic agent, for muscarinic receptors. Japanese Journal of Pharmacology (1987), 44(2), 222-4.
Oshita M, Ohashi T, Morikawa K, Kato H, Ito Y, Muramatsu I. Studies on the affinity and selectivity of tiquizium bromide (HSR-902), a novel spasmolytic agent, for muscarinic receptors. Jpn J Pharmacol. 1987 Jun;44(2):222-4.
Shioya, T.; Kagaya, M.; Sano, M.; Itaba, M.; Shindo, T.; Miura, M.; Antimuscarinic effect of tiquizium bromide in vitro and in vitro. European Journal of Clinical Pharmacology (1996), 50(5), 375-380.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.